Pseudane IX

CAS No. 55396-45-7

Pseudane IX( —— )

Catalog No. M35034 CAS No. 55396-45-7

Pseudane IX (2-nonyl-1H-quinolin-4-one) reduces infection of Huh 7.5 cells by hepatitis C virus (HCV) with an IC50 of 1.4 μg/ml.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 104 In Stock
10MG 155 In Stock
25MG 261 In Stock
50MG 369 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Pseudane IX
  • Note
    Research use only, not for human use.
  • Brief Description
    Pseudane IX (2-nonyl-1H-quinolin-4-one) reduces infection of Huh 7.5 cells by hepatitis C virus (HCV) with an IC50 of 1.4 μg/ml.
  • Description
    Pseudane IX, a compound isolated from the leaves of Ruta angustifolia, has strong anti-HCV activity with an IC50 value of 1.4 μg/mL. Pseudane IX reduces HCV RNA replication and viral protein synthesis levels.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    HCV Protease
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    55396-45-7
  • Formula Weight
    271.4
  • Molecular Formula
    C18H25NO
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CCCCCCCCCc1cc(=O)c2ccccc2[nH]1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Tutik Sri?Wahyuni, et al. Inhibition of hepatitis C virus replication by chalepin and pseudane IX isolated from?Ruta angustifolia?leaves.Fitoterapia.Volume 99,?December 2014, Pages 276-283.
molnova catalog
related products
  • 2-Hydroxydaidzein

    2'-Hydroxydaidzein

  • PUMA BH3

    PUMA BH3 is a p53 upregulated modulator of apoptosis (PUMA) BH3 domain peptide, acts as a direct activator of Bak, with a Kd of 26 nM.This is a PUMA BH3 domain peptide. PUMA proteins bind Bcl-2, localize to the mitochondria, and induce cytochrome C release and apoptosis in response to p53. PUMA may be a direct mediator of p53-induced apoptosis.

  • Bococizumab

    Bococizumab(PF-04950615) is a humanized mAb against PCSK9 and an inhibitor of the synthesis of PCSK9 in the liver that reduces the amount of low-density lipoprotein cholesterol (LDL-C) in the blood.Bococizumab is used to treat hypercholesterolemia.